Camden Capital, LLC Corcept Therapeutics Inc Transaction History

Camden Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$17.33 - $25.3 $161,914 - $236,377	-9,343 Closed	0 $0
Q1 2022 May 06, 2022	BUY	$16.53 - $25.21 $154,439 - $235,537	9,343 New	9,343 $210,000
Q3 2021 Nov 03, 2021	SELL	$19.68 - $22.53 $182,886 - $209,371	-9,293 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$19.97 - $24.43 $185,581 - $227,027	9,293 New	9,293 $204,000
Q1 2021 May 10, 2021	SELL	$23.49 - $30.56 $185,923 - $241,882	-7,915 Closed	0 $0

Q4 2020 Feb 04, 2021	BUY	$16.78 - $27.3 $132,813 - $216,079	7,915 New	7,915 $207,000

315

93.8M

2.02M

3.24M

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $3.38B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Camden Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Camden Capital, LLC with notifications on news.